A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant

NCT00005113 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

102

Enrollment

OTHER

Sponsor class

Stopped Inability to meet the accrual target of 213.

Conditions

End-Stage Renal Disease
Kidney Transplantation

Interventions

DRUG: Cyclosporine
DRUG: Sirolimus
DRUG: Tacrolimus

Sponsor

Boston Children's Hospital